Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nuwellis Inc NUWE

Healthcare Medical Devices
Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms... see more

Recent & Breaking News (NDAQ:NUWE)

CHF Solutions Appoints Nestor Jaramillo, Jr. as President and Chief Executive Officer

GlobeNewswire January 19, 2021

CHF Solutions Protects New Peripheral Vascular Access Catheter with Patent Application

GlobeNewswire January 12, 2021

CHF Solutions Announces Meta-Analysis Demonstrates Ultrafiltration is Better than Diuretic Therapy for the Management of Volume Overload in ADHF

GlobeNewswire December 15, 2020

CHF Solutions Announces Webinar on Pediatric Ultrafiltration Therapy hosted by Ladenburg Thalman & Co.

GlobeNewswire December 4, 2020

CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire November 23, 2020

CHF Solutions, Inc. Announces 52 Percent Increase in Revenue for Third Quarter 2020 and Provides Company Update

GlobeNewswire November 10, 2020

CHF Solutions, Inc. To Announce Third Quarter 2020 Financial Results on November 10, 2020

GlobeNewswire November 3, 2020

CHF Solutions Announces First Commercial Shipments of Aquadex Systems to Brazil, following Regulatory Approval

GlobeNewswire October 29, 2020

CHF Solutions Announces Deployment of Aquadex Systems to Hospitals in the Southeast to Treat COVID-19 Patients

GlobeNewswire October 27, 2020

CHF Solutions Submits Patent Application to Improve Venous Blood Flow and Ultrafiltration Efficiency

GlobeNewswire October 23, 2020

CHF Solutions Announces Data Demonstrating Benefit of Aquadex Therapy for Treatment of Heart Failure and COVID-19

GlobeNewswire October 7, 2020

CHF Solutions Initiatives at HFSA 24th Annual Scientific Meeting Highlight Aquadex Therapy Performance in Heart Failure

GlobeNewswire September 30, 2020

CHF Solutions to Share COVID-19 Experience with Leading Government Commission

GlobeNewswire September 23, 2020

CHF Solutions to Participate at Lake Street Capital Markets' 4th Annual BIG4 Conference on September 17, 2020

GlobeNewswire September 11, 2020

CHF Solutions' Physician-Led Webinar Concludes Fluid Overloaded Heart Failure Patients Benefit from Ultrafiltration

GlobeNewswire September 10, 2020

CHF Solutions Continues Physician-Led Webinar Series Discussing Precise Management of Fluid Overload in Patients with Acute Heart Failure

GlobeNewswire September 3, 2020

CHF Solutions Receives 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement

GlobeNewswire September 1, 2020

CHF Solutions Applauds U.S Congress Request to U.S. International Trade Commission to Identify Products to Treat COVID-19

GlobeNewswire August 27, 2020

CHF Solutions, Inc. Announces Closing of $14.37 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

GlobeNewswire August 21, 2020

CHF Solutions, Inc. Announces Pricing of $12.5 Million Underwritten Public Offering

GlobeNewswire August 19, 2020